Search - tctmd.com

Displaying 221 - 240 of 1500

Sort: Relevancy | Date

Presentation TCT 2024

TCT 674: Diagnosis of Coronary Microvascular Dysfunction With Invasive Coronary Function Testing: Insights From the DISCOVER INOCA Multicenter Registry

Presenter: Samit Shah

October 27, 2024

Presentation TCT 2024

TCT 678: Angina Severity and Symptom Improvement Are Associated With Diagnostic Acetylcholine Provocation Dose in Vasospastic Angina

Presenter: Caïa Crooijmans

October 27, 2024

Presentation TCT 2024

TCT 679: Coronary Microvascular Dysfunction in Patients With Cancer Experiencing Angina With Nonobstructive Coronary Arteries

Presenter: Abhishek Chaturvedi

October 27, 2024

Presentation ESC 2024

DCB with rescue stenting versus intended stenting for de novo CAD: a multicenter, non-inferiority trial

Presenter: Ling Tao

September 02, 2024

Presentation ESC 2024

OCEANIC-AF: Asundexian vs. Apixaban in Patients with Atrial Fibrillation

Presenter: Manesh R. Patel

September 01, 2024

Presentation ESC 2024

Edoxaban-Based Long-Term Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Disease: The EPIC-CAD Randomized Clinical Trial

Presenter: Gi-Byoung Nam

September 01, 2024

Presentation ESC 2024

NOTION-3: PCI in patients undergoing transcatheter aortic valve implantation

Presenter: Jacob Lønborg

August 31, 2024

Presentation EuroPCR 2024

One-month DAPT followed by 5-month Ti - cagrelor monotherapy in acute coronary syndromes with DCB - results from REC-CAGEFREE II

Presenter: Ling Tao

May 15, 2024

Presentation EuroPCR 2024

Methodological Insight: REC-CAGEFREE II Trial

Presenter: Robert Byrne

May 14, 2024

$Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)$

Presentation ACC 2024

Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)

Presenter: Rasha K. Al-Lamee

April 08, 2024

Presentation ACC 2024

Principal Results From the Double-blind, Placebo-controlled ULTIMATE-DAPT Trial

Presenter: Gregg W Stone

April 07, 2024

Presentation ACC 2024

Acoramidis May Improve Cardiac Function and Promote Regression in Transthyretin Amyloid Cardiomyopathy: Data From the ATTRibute-CM Cardiac Magnetic Resonance Substudy

Presenter: Yousuf Razvi

April 06, 2024

Presentation ACC 2024

ApoA-I Event ReducinG in Ischemic Syndromes II (AEGIS-II) Trial

Presenter: C. Michael Gibson

April 06, 2024

Presentation Miami Valves 2024

AI-driven Technologies to Guide Management of CAD Clinical Case

Presenter: Yiannis S. Chatzizisis

February 01, 2024

Presentation Controversies and Advances 2023

Decline in STEMI and Rising Prevalence of Non-obstructive CAD; What are the Contributing Risk Factors and Plaque Change?

Presenter: C. Noel Bairey Merz

November 30, 2023

Presentation AHA 2023

Two Randomized Controlled Trials of Nudges to Encourage Referrals to Centralized Pharmacy Services for Evidence-Based Statin Initiation in High-Risk Patients: The SUPER LIPID Program

Presenter: Alexander C. Fanaroff

November 13, 2023

Presentation Cardiovascular Interventions 2023

ICYMI: Drug Coated Balloons Have FINALLY Arrived: Here’s How I’m Going to Use Them!

Presenter: Ajay J. Kirtane

November 10, 2023

Presentation TCT 2023

TCT 781: Clinical outcomes of patients treated using 1-month dual antiplatelet therapy after biodegradable-polymer DES implantation

Presenter: Masaru Ishida

October 26, 2023

Presentation TCT 2023

TCT 406: Effect of Antithrombotic Strategies on Total Outcome Events in Patients with Atrial Fibrillation after Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights from AUGUSTUS

Presenter: Manasi Tannu

October 26, 2023

Presentation TCT 2023

TCT 215: Safety of Bivalirudin Versus Heparin in Patients With ST-elevation Myocardial Infarction: a Systematic Review and Meta-analysis:

Presenter: Mostafa Elbanna

October 26, 2023

Advertisement

TCT 674: Diagnosis of Coronary Microvascular Dysfunction With Invasive Coronary Function Testing: Insights From the DISCOVER INOCA Multicenter Registry

TCT 678: Angina Severity and Symptom Improvement Are Associated With Diagnostic Acetylcholine Provocation Dose in Vasospastic Angina

TCT 679: Coronary Microvascular Dysfunction in Patients With Cancer Experiencing Angina With Nonobstructive Coronary Arteries

DCB with rescue stenting versus intended stenting for de novo CAD: a multicenter, non-inferiority trial

OCEANIC-AF: Asundexian vs. Apixaban in Patients with Atrial Fibrillation

Edoxaban-Based Long-Term Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Disease: The EPIC-CAD Randomized Clinical Trial

NOTION-3: PCI in patients undergoing transcatheter aortic valve implantation

One-month DAPT followed by 5-month Ti - cagrelor monotherapy in acute coronary syndromes with DCB - results from REC-CAGEFREE II

Methodological Insight: REC-CAGEFREE II Trial

Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)

Principal Results From the Double-blind, Placebo-controlled ULTIMATE-DAPT Trial

Acoramidis May Improve Cardiac Function and Promote Regression in Transthyretin Amyloid Cardiomyopathy: Data From the ATTRibute-CM Cardiac Magnetic Resonance Substudy

ApoA-I Event ReducinG in Ischemic Syndromes II (AEGIS-II) Trial

AI-driven Technologies to Guide Management of CAD Clinical Case

Decline in STEMI and Rising Prevalence of Non-obstructive CAD; What are the Contributing Risk Factors and Plaque Change?

Two Randomized Controlled Trials of Nudges to Encourage Referrals to Centralized Pharmacy Services for Evidence-Based Statin Initiation in High-Risk Patients: The SUPER LIPID Program

ICYMI: Drug Coated Balloons Have FINALLY Arrived: Here’s How I’m Going to Use Them!

TCT 781: Clinical outcomes of patients treated using 1-month dual antiplatelet therapy after biodegradable-polymer DES implantation

TCT 406: Effect of Antithrombotic Strategies on Total Outcome Events in Patients with Atrial Fibrillation after Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights from AUGUSTUS

TCT 215: Safety of Bivalirudin Versus Heparin in Patients With ST-elevation Myocardial Infarction: a Systematic Review and Meta-analysis:

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content